RelB Upregulates PD-L1 and Exacerbates Prostate Cancer Immune Evasion

0
13
Researchers described that RelB participated in the immune evasion of prostate cancer via cis/trans transcriptional upregulation of programmed death receptor ligand (PD-L1).
[Journal of Experimental & Clinical Cancer Research]
Full Article